<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04451551</url>
  </required_header>
  <id_info>
    <org_study_id>15O-H2O PET Cohort</org_study_id>
    <nct_id>NCT04451551</nct_id>
  </id_info>
  <brief_title>Myocardial Perfusion Imaging by 15O-H2O PET/CT</brief_title>
  <official_title>Myocardial Perfusion Imaging by 15O-H2O PET/CT: Reference Values and Prognostic Value</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial will include 2500 patients with evident or suspected ischemic heart disease refered&#xD;
      to Department of Nuclear Medicine &amp; PET Centre, Aarhus University Hospital, for perfusion&#xD;
      imaging by 15O-H2O PET/CT scan of the heart during rest and stress. The patients will undergo&#xD;
      the clinical scan as normal.&#xD;
&#xD;
      Data from the scans will be used to determine reference values of the examination.&#xD;
&#xD;
      Follow up will be done for up to 10 years in regards to major cardiovascular events in order&#xD;
      to determine the prognostic value of the scan.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 23, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2033</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Prognostic value within 10 years</measure>
    <time_frame>10 years</time_frame>
    <description>Number of participants who experience a major adverse cardiac event within 10 years of follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial blood flow</measure>
    <time_frame>5 Years</time_frame>
    <description>The myocardial blood flow of participants assessed by 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronary flow reserve</measure>
    <time_frame>5 Years</time_frame>
    <description>The coronary flow reserve of participants assessed by 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary transit time</measure>
    <time_frame>5 Years</time_frame>
    <description>The pulmonary transit time of participants assessed by 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular end-systolic volume</measure>
    <time_frame>5 Years</time_frame>
    <description>The left ventricular end-systolic volume of participants assessed by 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular end-diastolic volume</measure>
    <time_frame>5 Years</time_frame>
    <description>The left ventricular end-diastolic volume of participants assessed by 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular end-systolic volume</measure>
    <time_frame>5 Years</time_frame>
    <description>The right ventricular end-systolic volume of participants assessed by 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular end-diastolic volume</measure>
    <time_frame>5 Years</time_frame>
    <description>The right ventricular end-diastolic volume of participants assessed by 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate coronary angiography followup</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants who undergo coronary angiography within 3 months after primary 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate percutaneous coronary intervention (PCI) followup</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants who undergo percutaneous coronary intervention within 3 months after primary 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate coronary artery bypass graft (CABG) followup</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants who undergo coronary artery bypass graft within 3 months after primary 15O-H2O PET/CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value within 5 years</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants who experience a major adverse cardiac event within 5 years of follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value within 2 years</measure>
    <time_frame>2 years</time_frame>
    <description>Number of participants who experience a major adverse cardiac event within 2 years of follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value within 1 years</measure>
    <time_frame>1 years</time_frame>
    <description>Number of participants who experience a major adverse cardiac event within 1 years of follow-up.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient with known or suspected ischemic heart disease referred for a clinical H2O-PET&#xD;
        at Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, not meeting&#xD;
        any exclusion criteria will be enrolled in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Known or suspected ischemic heart disease referred for a clinical H2O-PET at&#xD;
             Department of Nuclear Medicine and PET Centre, Aarhus University Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Claustrophobia, severe asthma, younger than 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Simon Madsen, MD</last_name>
    <phone>4520140596+</phone>
    <email>simmas@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Aarhus N</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Madsen</last_name>
      <email>simmas@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 23, 2020</study_first_submitted>
  <study_first_submitted_qc>June 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2020</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial Perfusion Imaging</keyword>
  <keyword>Positron-Emission Tomography</keyword>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Coronary Flow Reserve</keyword>
  <keyword>Myocardial Blood Flow</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Reference Value</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

